RenovoRx amends bylaws for universal proxy rules; appoints Dr. Spiegel to Compensation Committee

RenovoRx, Inc.

Board reduced stockholder meeting quorum from majority to one-third of voting power.
Enhanced disclosure requirements for stockholder nominations and proposals, aligning with Rule 14a-19.
Modified adjournment procedures and list of stockholders per DGCL amendments.
Dr. Robert Spiegel appointed to Compensation Committee; full committee rosters disclosed.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

RenovoRx, Inc.: Reduced stockholder meeting quorum requirement from a majority to one-third of voting power and enhanced procedural mechanics for stockholder nominations and proposals, including Universal Proxy Rule compliance (effective 2023-09-07).

Change: bylaw amendment
Effective: 2023-09-07

Exact text from the filing

On September 7, 2023, in connection with the adoption of Rule 14a-19 (the “Universal Proxy Rules”) under the Securities Exchange Act of 1934, as amended, certain recent changes to the Delaware General Corporation Law (the “DGCL”), and a periodic review of the bylaws of RenovoRx, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) adopted amended and restated bylaws (the “Amended and Restated Bylaws”), effective immediately

View on SEC.gov

Browse all governance changes →

RenovoRx, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-032160

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.